New Advance to the Theranexus and BBDF Batten-1 Program for

LYON, FRANCE and AUSTIN, TX / ACCESSWIRE / January 5, 2023 / Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development of drug candidates

Related Keywords

United States , Paris , France General , France , San Francisco , California , French , Craig Benson , Thierry Lambert , Marie Sebille , Florence Portejoie , Martin Pierre Laurent , National Organization For Rare Disorders , Neuroscience Innovation Forum , Twitter , Atomic Energy Commission , Batten Disease Foundation , Sachs Associates , Beyond Batten Disease Foundation , Theranexu Chief Medical Officer Marie Sebille , Annual Neuroscience Innovation Forum , Biotech Showcase , Healthcare Conference , Unified Batten Disease Rating Scale , French Alternative Energies , Euronext Growth , Rare Disorders , Advance , Theranexus , Bbdf , Thatten , Program , Juvenile , Disease ,